Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Zymeworks (ZYME) Current Leases (2021 - 2025)

Zymeworks' Current Leases history spans 5 years, with the latest figure at $3.5 million for Q4 2025.

  • On a quarterly basis, Current Leases rose 26.68% to $3.5 million in Q4 2025 year-over-year; TTM through Dec 2025 was $3.5 million, a 26.68% increase, with the full-year FY2025 number at $3.5 million, up 26.68% from a year prior.
  • Current Leases hit $3.5 million in Q4 2025 for Zymeworks, up from $3.4 million in the prior quarter.
  • Over the last five years, Current Leases for ZYME hit a ceiling of $4.6 million in Q3 2022 and a floor of $1.3 million in Q4 2021.
  • Historically, Current Leases has averaged $3.4 million across 5 years, with a median of $3.4 million in 2025.
  • Biggest five-year swings in Current Leases: soared 153.59% in 2022 and later plummeted 35.7% in 2024.
  • Tracing ZYME's Current Leases over 5 years: stood at $1.3 million in 2021, then surged by 153.59% to $3.3 million in 2022, then grew by 28.27% to $4.3 million in 2023, then crashed by 35.7% to $2.7 million in 2024, then increased by 26.68% to $3.5 million in 2025.
  • Business Quant data shows Current Leases for ZYME at $3.5 million in Q4 2025, $3.4 million in Q3 2025, and $3.6 million in Q2 2025.